Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.82 HKD | 0.00% | 0.00% | -10.87% |
Apr. 30 | LH Group Limited Announces Board and Committee Changes | CI |
Apr. 29 | Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy | MT |
Sales 2022 | 1.07B 137M | Sales 2023 | 1.28B 164M | Capitalization | 736M 94.26M |
---|---|---|---|---|---|
Net income 2022 | 77M 9.86M | Net income 2023 | 88M 11.27M | EV / Sales 2022 | 0.69 x |
Net cash position 2022 | 118M 15.14M | Net Debt 2023 | 2.46M 315K | EV / Sales 2023 | 0.58 x |
P/E ratio 2022 |
11
x | P/E ratio 2023 |
8.36
x | Employees | 1,291 |
Yield 2022 |
7.26% | Yield 2023 |
9.58% | Free-Float | 25% |
1 month | -1.20% | ||
3 months | -14.58% | ||
6 months | -9.89% | ||
Current year | -10.87% |
Managers | Title | Age | Since |
---|---|---|---|
Kit Lung Wong
CEO | Chief Executive Officer | 50 | 17-06-19 |
Dong John Yang
DFI | Director of Finance/CFO | 49 | 23-04-10 |
Hiu Yi Chan
ADM | Chief Administrative Officer | 38 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wai Man Hung
BRD | Director/Board Member | 55 | 18-05-29 |
Kit Lung Wong
CEO | Chief Executive Officer | 50 | 17-06-19 |
Sau Chee Ko
BRD | Director/Board Member | 58 | 17-06-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 0.82 | 0.00% | 44 000 |
24-06-04 | 0.82 | -1.20% | 210,000 |
24-06-03 | 0.83 | +1.22% | 1,044,000 |
24-05-31 | 0.82 | +1.23% | 166,000 |
24-05-30 | 0.81 | -1.22% | 428,000 |
Delayed Quote Hong Kong S.E., June 04, 2024 at 09:49 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.87% | 84.91M | |
+13.88% | 8.43B | |
+65.96% | 3.19B | |
-5.59% | 2.1B | |
+11.25% | 1.99B | |
+8.63% | 1.73B | |
-31.47% | 1.7B | |
+1.55% | 1.47B | |
-17.38% | 897M | |
-4.12% | 822M |
- Stock Market
- Equities
- 1978 Stock